EANM/EARL harmonization strategies in PET quantification: from daily practice to multicentre oncological studies

N Aide, C Lasnon, P Veit-Haibach, T Sera… - European journal of …, 2017 - Springer
Quantitative positron emission tomography/computed tomography (PET/CT) can be used as
diagnostic or prognostic tools (ie single measurement) or for therapy monitoring (ie …

FDG PET/CT for assessing tumour response to immunotherapy: Report on the EANM symposium on immune modulation and recent review of the literature

N Aide, RJ Hicks, C Le Tourneau, S Lheureux… - European journal of …, 2019 - Springer
This paper follows the immunotherapy symposium held during the European Association of
Nuclear Medicine (EANM) 2017 Annual Congress. The biological basis of the immune …

Joint EANM/SNMMI/ANZSNM practice guidelines/procedure standards on recommended use of [18F]FDG PET/CT imaging during immunomodulatory treatments in …

E Lopci, RJ Hicks, A Dimitrakopoulou-Strauss… - European journal of …, 2022 - Springer
Purpose The goal of this guideline/procedure standard is to assist nuclear medicine
physicians, other nuclear medicine professionals, oncologists or other medical specialists …

New PET technologies–embracing progress and pushing the limits

N Aide, C Lasnon, A Kesner, CS Levin, I Buvat… - European journal of …, 2021 - Springer
Thanks to companies' research and development processes, frequently involving fruitful
partnerships with academic centres, and what could be acknowledged as welcome …

EANM guideline on the role of 2-[18F]FDG PET/CT in diagnosis, staging, prognostic value, therapy assessment and restaging of ovarian cancer, endorsed by the …

RC Delgado Bolton, N Aide, PM Colletti… - European journal of …, 2021 - Springer
In most patients with ovarian carcinoma, the diagnosis is reached when the disease is long
past the initial stages, presenting already an advanced stage, and they usually have a very …

Advances in PET/CT technology: an update

N Aide, C Lasnon, C Desmonts, IS Armstrong… - Seminars in nuclear …, 2022 - Elsevier
This article reviews the current evolution and future directions in PET/CT technology
focusing on three areas: time of flight, image reconstruction, and data-driven gating. Image …

Machine learning predictive performance evaluation of conventional and fuzzy radiomics in clinical cancer imaging cohorts

M Grahovac, CP Spielvogel, D Krajnc, B Ecsedi… - European Journal of …, 2023 - Springer
Background Hybrid imaging became an instrumental part of medical imaging, particularly
cancer imaging processes in clinical routine. To date, several radiomic and machine …

Predictive value of PET response combined with baseline metabolic tumor volume in peripheral T-cell lymphoma patients

AS Cottereau, TC El-Galaly, S Becker… - Journal of Nuclear …, 2018 - jnm.snmjournals.org
Peripheral T-cell lymphoma (PTCL) is a heterogeneous group of aggressive non-Hodgkin
lymphomas with poor outcomes on current therapy. We investigated whether response …

Repeatability of [18F]FDG PET/CT total metabolic active tumour volume and total tumour burden in NSCLC patients

GD Kolinger, D Vállez García, GM Kramer, V Frings… - EJNMMI research, 2019 - Springer
Background Total metabolic active tumour volume (TMATV) and total tumour burden (TTB)
are increasingly studied as prognostic and predictive factors in non-small cell lung cancer …

Why harmonization is needed when using FDG PET/CT as a prognosticator: demonstration with EARL-compliant SUV as an independent prognostic factor in lung …

B Houdu, C Lasnon, I Licaj, G Thomas, P Do… - European journal of …, 2019 - Springer
Background To determine EARL-compliant prognostic SUV thresholds in a mature cohort of
patients with locally advanced NSCLC, and to demonstrate how detrimental it is to use a …